Virogenomics BioDevelopment recognize the challenge of advancing early stage technology out of the lab and into the marketplace.
Virogenomics BioDevelopment recognize the challenge of advancing early stage technology out of the lab and into the marketplace. Their goal is to help bridge this gap. They work with technology leaders at universities and small biotech companies to help them determine the full potential of their technology and a path forward that maximizes its impact. They have experience and expertise in bringing together the scientific, regulatory, and funding pieces that are necessary for success. Although Virogenomics BioDevelopment is a new company, the executive team and board of directors have been focused on early stage technologies for over a decade. Located in the beautiful Pacific Northwest, the team collaborates with partners across the United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2018 | Series Unknown | — | 1 | — | — | Detail |
Mar 23, 2012 | Grant | $587.39K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Reference Capital | — | Series Unknown |